29 March 2021 – GoPuff Secures $1.15bn in Round Including SoftBank

The Big Ones

On-demand consumer product delivery service GoPuff has experienced some major league growth of late, and has secured $1.15bn from investors including SoftBank Vision Fund 1 in a round lifting its valuation from $3.9bn to $8.9bn. The $3.9bn valuation had been achieved just five months ago, in a $380m round that also featured Vision Fund 1.

We’re still seeing a good amount of reverse merger deals being agreed but one of the biggest in recent times has just been announced by content monetisation software provider IronSource. The Access Industries-backed company has agreed to join forces with special purpose acquisition company Thoma Bravo Advantage at an $11.1bn pro forma equity. IronSource’s valuation was reportedly not much larger than $1bn in its last round, less than 18 months ago.

Japan-based medical supplies vendor Medipal Holdings has partnered SBI Investment, an investment subsidiary of financial services firm SBI Holdings, to form a ¥10bn ($92m) corporate venture capital vehicle. Medipal Innovation Fund is intended to operate for 10 years and will mainly target domestic and international startups developing technologies strategically relevant to Medipal’s business lines.

Crossover Deal

Evidation Health, a US-based health data analysis provider, has picked up $153m in a series E round co-led by healthcare consortium Kaiser Permanente’s Group Trust. The round was co-led by Omers Growth Equity, a fund managed by pension fund Ontario Municipal Employees Retirement System, and included McKesson Ventures, the corporate venturing arm of medical supplies distributor McKesson, as well as venture capital firm B Capital Group. The round valued it at $1bn, according to Bloomberg. So far, so normal. Evidation’s technology platform, Achievement, records raw behaviour data such as speech and video from patients’ electronic devices and analyses it to provide insights on health and disease. But its origin is where it gets unusual: the company was founded in 2012 through a partnership between Stanford Health Care, the academic health system of Stanford University, and GE Ventures, a corporate venturing subsidiary of General Electric. It’s not a type of story we see often, but with now $259m in capital, the model is clearly working out for Evidation.

Deals

Dataminr has closed a $475m funding round that hiked its valuation to $4.1bn. The company, which counts Credit Suisse Next Investors as an earlier backer, provides software that pools information from a range of public sources to detect events and track trends in real time, and will put the proceeds from the round into international customer acquisition.

China-based CasiCloud provides production automation software for the aerospace industry, and has secured $404m in funding, becoming the latest automation technology provider to raise big money, in the wake of several robotic process automation-focused companies over the past year. Its earlier investors include China Aerospace Science and Industry Corporation but the latest round was co-led by China Merchants Capital, ICBC Capital and Shenzhen Capital.

Sports memorabilia retailer Fanatics has pulled in $320m through a round that doubled its valuation to $12.8bn in the space of seven months. SoftBank is also among Fanatics’ investors, as is Alibaba, and the latest round included Major League Baseball, Fidelity Investments, Franklin Templeton, Neuberger Berman, Silver Lake and Thrive Capital. It came as the company undertakes a growth push centred on China.

Crypto wallet and exchange operator Blockchain.com is growing even faster, and has secured $300m in series C funding at a $5.2bn valuation, roughly five weeks after a $120m series B round valuing it at $3bn. GV and Access Industries were among the participants in the latter round, with GV having been an investor in the company since 2017.

Airwallex is the creator of a cloud software platform that helps businesses expand globally by coordinating finance activities across multiple currencies. It has raised $100m from investors including ANZ Bank’s ANZi Ventures vehicle to increase its series D round to $300m. The extension represents the third tranche of the round, with Tencent and Salesforce Ventures among the earlier backers. Airwallex is now valued at $2.6bn.

If grocery delivery services like Instacart have experienced considerable growth during the coronavirus pandemic, Germany-based Gorillas almost makes that growth look lazy. The company was founded less than a year ago but has just secured $290m in a series B round featuring Tencent that valued it above $1bn. That makes Gorillas, by its reckoning, the quickest European startup ever to exceed a $1bn valuation. And its service is currently available in just 13 European cities.

Komodo Health, the developer of a healthcare tracking software platform, has meanwhile raised $220m at a $3.3bn valuation, in its series E round only two months after notching up $44m in series D funding. The series D round included long-term corporate investor McKesson Ventures, and it has now secured a total of $314m in just 14 months.

Funds

Japan-based financial services firm Juroku Bank has formed a venture capital unit dubbed Nobunaga Capital Village and a startup accelerator called Juroku Bank Accelerator 2021. Nobunaga Capital Village will be launched in April 2021 with ¥4.5bn ($41.2m) of capital across two vehicles, and will target developers of financial technology and local economy revitalisation projects, focusing on the Chūbu region where the bank is headquartered.

Exits

Supply chain finance provider Linklogis has filed for an initial public offering on the Hong Kong Stock Exchange and set terms that will see it raise $1.06bn if it floats at the top of its range. Bertelsmann Asia Investments, Tencent, GLP, Skyworth and Standard Chartered are all among the company’s investors, and the offering will be anchored by $365m from institutional investors including BlackRock and Fidelity.

Another Chinese company, online Q+A platform developer Zhihu, is going public in the US today in a $523m initial public offering that scores exits for Kuaishou, Tencent, Baidu, Sogou and Sunshine Insurance. The company priced the shares at the foot of the IPO’s range, but it will be buoyed by a $250m private placement being provided by Tencent and fellow corporates Alibaba, JD.com and Lilith Games.

Olo has closed its initial public offering at approximately $518m after the underwriters took up the option to buy an additional $67.5m shares. The PayPal-backed restaurant ordering software provider floated above its range on the New York Stock Exchange last week and its share price subsequently increased by upwards of 20%.

Online automotive marketplace ACV Auctions raised $5m for a series A round five years ago, and now it’s gone public in an initial public offering sized at about $416m. The SoftBank-backed company priced its shares above an already increased range, and the price rose again yesterday, giving ACV a market cap around the $4.8bn mark at close of trading.

Rockley Photonics, a silicon photonic chipmaker that counts Applied Materials and Hengtong Optic-Electric among its investors, is set to list through a reverse takeover with special purpose acquisition company SC Health Corp at a $1.2bn post-merger valuation. Medtronic is among the investors supplying $150m in PIPE financing to support the deal, announced as Rockley prepares to commercially launch its unique sensing platform.

Autonomous truck developer TuSimple is still pre-revenue but has filed for an initial public offering in the United States. The China-based company has raised roughly $650m in funding and its investors include corporates Sina, Navistar, Traton, Nvidia, Mando, UPS, Goodyear, Union Pacific, CN, Kroger and US Xpress. Media reports in August 2020 suggested it could target a valuation of up to $7bn in the IPO.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

07 October 2019 – We Co Pulls IPO

We Co, otherwise known as WeWork, formally pulled its initial public offering last week, putting a cap on what will go down as one of the most disastrous attempts to go public in recent memory. So what does that mean for corporate venturers? Is the co-working space still viable? Is it still worth betting on visionary founders? And what about SoftBank? If those are questions you’d like answers to, do check out GCV news editor Robert Lavine’s analysis on GlobalCorporateVenturing.com

Big Ones

Udaan, the Indian operator of an e-commerce platform that links small businesses to large traders and wholesalers, has raised $585m in series D funding from investors including Tencent and Citi Ventures to take its total equity financing to $870m in under three years.

Online content and advertising platforms Taboola and Outbrain operate in a relatively similar space and have elected to join forces, with Taboola buying the latter for $250m in cash, and $600m in stock equating to a 30% stake in what will be a $2bn company.

Oxford Sciences Innovation (OSI), the university venture fund for University of Oxford, has added China-based telecommunications equipment and services provider Huawei as a limited partner. Huawei is believed to have bought 4.1 million shares over the past year through a Netherlands-based subsidiary called Huawei Technologies Cooeperatief, taking its stake in OSI to about 0.7%. Huawei has never been listed on OSI’s website as a backer. The deal was concluded in late 2018 before University of Oxford blocked the firm’s philanthropic donations due to fears over its influence in the UK technology space.

Deals

IronSource has confirmed a $400m+ investment by private equity firm CVC Capital Partners at a 10-figure valuation. The content monetisation and engagement platform developer raised $105m in a 2015 series A round featuring Access Industries at an apparently similar valuation, though Calcalist reported earlier this week that its shareholders regularly receive sizeable dividends, which would largely offset any flatlining in company value.

Electric scooter and bike rental service Bird has raised $275m at a $2.75bn post-money valuation, in a series D round co-led by Sequoia Capital and pension fund manager CDPQ.

Rapyd has already raised $100m, through a series C round featuring Stripe that valued the digital payment software producer at almost $1bn.

Tenaya Therapeutics, a US-based developer of treatments for heart disease, completed a $92m series B round on Thursday featuring GV, a corporate venturing subsidiary of internet and technology group Alphabet. The round was led by healthcare investment firm Casdin Capital and included Column Group and a range of undisclosed new and existing shareholders.

Adicet Bio is meanwhile working on cancer treatments that will utilise gamma delta T cells, and has completed an $80m series B round that took its total funding to $131m.

US-based vaccine developer Icosavax emerged from stealth on Thursday with $51m of series A funding from investors including Sanofi Ventures, the corporate venturing arm of pharmaceutical firm Sanofi. Qiming Venture Partners USA led the round, which was also backed by NanoDimension, Adams Street Partners and undisclosed existing investors.

Funds

Non-profit health system Advocate Aurora Health and Wisconsin Alumni Research Foundation (Warf), the commercialisation arm of University of Wisconsin-Madison, have become a limited partner in a $75m healthcare-focused fund raised by venture capital firm Venture Investors.

Exits

It’s been a rough ride recently for companies trying to go public: Peloton’s shares have crashed every day since going public and that’s before we get to the disaster that’s been We Company’s struggles. But that isn’t stopping others from chasing the dream and Progyny has filed for a $100m offering on Nasdaq that would provide exits to SR One and Merck Group

36Kr will be hoping its own IPO goes better. The China-based startup media and services company has filed to go public in the US and has set an initial target of $100m. Its investors include Alibaba affiliate Ant Financial and media group Nikkei, and it will be hoping it doesn’t fall foul of reported plans by Nasdaq – the operator of the market on which it intends to float – to tighten regulations for smaller IPOs by Chinese companies which have sometimes chiefly sold shares to investors linked to their executives. With only two named underwriters in the 36Kr IPO, that could be a factor.

Harvard University spinout Beam Therapeutics has filed for its own $100m IPO, which will follow roughly $225m in funding raised across two rounds. The genomic medicine developer’s shareholders include GV and Editas Medicine, the latter having acquired a stake through a licensing agreement last year.

4D Molecular Therapeutics has filed for a $100m initial public offering that will fund the progress of gene therapies for conditions such as Fabry disease and cystic fibrosis. It has raised at least $108m, $90m of which came in a 2018 series B round that included Pfizer Ventures and Chiesi Ventures.

MIT and Harvard spinout Frequency Therapeutics has gone public in an $84m initial public offering that represents a bit of a downgrade on its expectations, the company floating at the bottom of its range and cutting the number of shares in the IPO.

Live streaming software and tools provider Streamlabs has also achieved its own exit, agreeing to an acquisition by Logitech International for up to $118m. The total’s split between an $89m upfront cash payment – slightly more than Streamlabs’ most recent post-money valuation of $80m – and $29m worth of stock dependent on it reaching significant revenue growth.

Aprea Therapeutics, a US-based cancer drug developer spun out of Karolinska Institute and backed by its investment Karolinska Development as well as healthcare provider Praktikertjänst, has raised $85m in an initial public offering on the Nasdaq Global Select Market.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0